|
Duncan Learmouth was appointed Senior Vice President, Corporate Communications and Community Partnerships in July 2006. He is a member of the Corporate Executive Team. He was previously Vice President, Global Investor Relations and Competitive Excellence.
Duncan joined Glaxo Wellcome in 1991 and joined the Investor Relations department in 1997. In December 2000, after the merger of Glaxo Wellcome and SmithKline Beecham he was appointed Vice President of Investor Relations. In November 2001 he was appointed Vice President, Global Investor Relations with responsibility for the global IR function, reporting to the CFO. In February 2006 he added the competitive excellence function to his responsibilities, which reports to the CEO, and includes the role of secretary to the CET, GSK’s Executive Committee.
Prior to Investor Relations, Duncan was a Senior Financial Analyst within the Corporate Finance department responsible for the Group’s strategic plan. He has also been Financial Controller of Adechsa SA based in Zug, Switzerland and worked in the Financial Investigations and Trading Arrangements departments, both also part of Corporate Finance.
Before moving to Glaxo Wellcome, Duncan was with Deloitte and Touche in London from 1988, qualifying as a Chartered Accountant in 1991. Duncan was educated at Durham University where he gained a degree in Chemistry. | 